Rockwell Medical, Inc. - Special Call Transcript
Good afternoon, and welcome to the Rockwell Medical 2020 Management and KOL Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Russell Ellison, President and CEO. Dr. Ellison, please go ahead.
Good afternoon. It is a pleasure to speak with you all. On behalf of myself and the management team at Rockwell Medical, I'd like to thank you for joining us for this important update. The purpose of today's call is to make you aware of plans we have to pursue new indication opportunities for our innovative platform technology, ferric pyrophosphate citrate, or FPC.
FPC is a true second-generation parenteral iron. It was developed to replace iron loss in patients with anemia in an entirely different way. This unique and differentiated molecule provides a novel mechanism of action with a physiologic approach. FPC donates iron directly to circulating transferrin, making it immediately bioavailable for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
